首页> 外文期刊>Frontiers in Microbiology >Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics
【24h】

Mycoplasma pneumoniae: Current Knowledge on Nucleic Acid Amplification Techniques and Serological Diagnostics

机译:肺炎支原体:核酸扩增技术和血清学诊断的最新知识

获取原文
           

摘要

Mycoplasma pneumoniae ( M. pneumoniae ) belongs to the class Mollicutes and has been recognized as a common cause of respiratory tract infections (RTIs), including community-acquired pneumonia (CAP), that occur worldwide and in all age groups. In addition, M. pneumoniae can simultaneously or sequentially lead to damage in the nervous system and has been associated with a wide variety of other acute and chronic diseases. During the past 10 years, the proportion of LRTI in children and adults, associated with M. pneumoniae infection has ranged from 0 to more than 50%. This variation is due to the age and the geographic location of the population examined but also due to the diagnostic methods used. The true role of M. pneumoniae in RTIs remains a challenge given the many limitations and lack of standardization of the applied diagnostic tool in most cases, with resultant wide variations in data from different studies. Correct and rapid diagnosis and/or management of M. pneumoniae infections is, however, critical to initiate appropriate antibiotic treatment and is nowadays usually done by PCR and/or serology. Several recent reviews, have summarized current methods for the detection and identification of M. pneumoniae . This review will therefore provide a look at the general principles, advantages, diagnostic value, and limitations of the most currently used detection techniques for the etiological diagnosis of a M. pneumoniae infection as they evolve from research to daily practice.
机译:肺炎支原体(M. pneumoniae)属于Mollicutes类,已被公认是呼吸道感染(RTIs)的常见原因,包括社区获得性肺炎(CAP),其在世界各地和所有年龄组中均发生。此外,肺炎支原体可同时或依次导致神经系统损伤,并与多种其他急性和慢性疾病有关。在过去的十年中,与肺炎支原体感染相关的儿童和成年人中LRTI的比例为0%至50%以上。这种变化是由于所检查人群的年龄和地理位置,也归因于所使用的诊断方法。鉴于大多数情况下所应用的诊断工具存在诸多局限性和缺乏标准化,因此肺炎支原体在RTIs中的真正作用仍然是一个挑战,因此不同研究的数据差异很大。然而,正确和快速地诊断和/或控制肺炎支原体感染对于启动适当的抗生素治疗至关重要,并且如今通常通过PCR和/或血清学来完成。最近的一些评论总结了检测和鉴定肺炎支原体的当前方法。因此,本综述将探讨从肺炎支原体感染到研究的日常发展过程中,最常用的检测技术用于肺炎支原体感染的病因学诊断的一般原理,优点,诊断价值和局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号